Loading
institutionsInstitution
Tongji Hospital, Huazhong University of Science and Technology
Tongji Hospital in Wuhan is Central China's largest hospital; its cancer centre enrols into domestic PD-1, antibody-drug conjugate and targeted therapy registration trials, and Ding Ma's group leads national research on cervical and ovarian cancer and HPV.
Also called: Tongji Hospital Wuhan同济医院
Overview
Tongji Hospital, founded in Shanghai in 1900 and relocated to Wuhan in 1955, is the flagship of Tongji Medical College of Huazhong University of Science and Technology. Its Cancer Center is one of the largest in China with wide participation in domestic PD-1, ADC and targeted therapy registration trials, and the hospital is a national leader in gynaecological oncology (Ding Ma's group on cervical and ovarian cancer and HPV), haematology, urology and hepatobiliary surgery. Tongji is a national clinical research centre for obstetric and gynaecological disease and runs a large biobank and organoid platform.
Location
Wuhan, CN
Type
hospital · Huazhong University of Science and Technology
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#188 · 30 points (0 Newsweek + 0 NCI + 30 from 15 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Huazhong University of Science and Technology, including child institutions. 2,478 works · 31,527 citations · 77% open access · 10% clinical trials · 3% reviews.
Oncology works per year
5242022
5602023
5202024
5292025
3452026
Most works
- Heng Mei93 works
- Liang Huang67 works
- Chunrui Li45 works
- Qian Chu44 works
- Yu Hu42 works
- Jianfeng Zhou41 works
- Qinglei Gao38 works
- Xiaojian Zhu37 works
- Yicheng Zhang35 works
- Yinqiang Zhang34 works
Most cited
- Gynaecological oncology
- Cancer Center trial portfolio
- Haematology
- Hepatobiliary surgery
Similar pages
- Key paperEquecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma: The FUMANBA-1 Nonrandomized Clinical Trial
Shares FUMANBA-1, Equecabtagene autoleucel.
- InstitutionUganda Cancer Institute
Shares HPV & HBV vaccination, Cervical cancer, Hepatocellular carcinoma, Diffuse large B-cell lymphoma.
- IdeaEliminate infection-caused cancers: HPV, hepatitis B and C, H. pylori and EBV
Shares HPV & HBV vaccination, Cervical cancer, Hepatocellular carcinoma.
- InstitutionPeking Union Medical College Hospital
Shares Union Hospital, Tongji Medical College, Cervical cancer, Ovarian cancer.
- JournalTumour virus research
Shares HPV & HBV vaccination, Cervical cancer, Hepatocellular carcinoma.
- TrialA Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)
- IdeaA delivery-science moonshot for prevention we already own
Shares HPV & HBV vaccination, Cervical cancer, Hepatocellular carcinoma.
- InstitutionDharmais National Cancer Center
Shares HPV & HBV vaccination, Cervical cancer, Hepatocellular carcinoma.
cancers
fronts
technologies
drugs
ApprovedCell therapy (autologous BCMA CAR-T, fully human binder)
Equecabtagene autoleucel · Fucaso